Navigation Links
Bayer HealthCare Cleared to Acquire Citracal(R)
Date:10/5/2007

Addition of Leading Calcium Brand Enriches Consumer Care Division's Key

Nutritionals Product Portfolio

MORRISTOWN, N.J., Oct. 5 /PRNewswire/ -- Bayer HealthCare (BHC) announced today that its Consumer Care Division has received regulatory approvals necessary to acquire the Citracal(R) line of over-the-counter (OTC) calcium supplements in the United States. The U.S. portion of the transaction with Mission Pharmacal was closed yesterday evening at which point Bayer assumed full management of the business in the U.S.

As indicated earlier this year when the proposed acquisition was announced, the addition of Citracal increases Bayer Consumer Care's market presence in the United States, the world's largest OTC market. It will also continue to build upon the company's already strong nutritionals business, which includes leading brands such as One-A-Day(R), Supradyn(R), Berocca(R) and Redoxon(R).

"We're excited to take ownership of the Citracal brand as it offers very attractive growth potential both in the critically important US market and for our nutritionals portfolio, which is a key growth driver for us now and in the future," said Gary Balkema, President of Bayer HealthCare's Consumer Care Division.

Citracal is primarily sold in North America and saw net sales of $47.0 million (EUR 36.2 million) for fiscal year 2007.

About Bayer HealthCare AG

Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma and as Bayer HealthCare Pharmaceuticals in the US and Canada. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide.

Abou
'/>"/>

SOURCE Bayer HealthCare
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
2. Bayer Wins Positive Response For Marketing Its Cancer Drug
3. Genomatix Licensed By Bayer Healthcare
4. Bayer to Market Biocon Insulin in China
5. Test for Esophageal Reflux Licensed to Bayer by University
6. Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
7. Dow Acquires Wolff Walsrode from Bayer
8. Healthcare sector is now a multi billion-dollar industry in India
9. Iodex goes to SmithKline Beecham consumer Healthcare
10. Healthcare Professionals Might Want To Rethink Their Dress Code
11. WHO report asks for improved healthcare for mother and child
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... York (PRWEB) May 23, 2013 ... C.R. Bard, Inc., continue to move forward in a ... District of West Virginia, Bernstein Liebhard LLP reports. ... denied a request by C.R. Bard to seal emails ... trade secrets and other confidential, proprietary information about its ...
(Date:5/23/2013)... Spring and summer have always been motivation ... Jackson , the city between Memphis and Nashville? In the ... wellness centers has transformed the growing area into one of ... any city of vibrant, young professionals you are going to ... Kim White, owner of The Fight Shop, one of the ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Parker Waichman ... rights of victims injured by defective medical devices and ... Matthew J. McCauley has been appointed Co-Lead Counsel in ... IUD Products Liability Litigation (Case 7:13-md-02434-CS). The Order, which ... Liaison Counsel are to submit their proposal for the ...
(Date:5/23/2013)... News) -- The sensation of itching is hardwired into ... a small molecule released in the spinal cord, according ... say this molecule, known as natriuretic polypeptide b (Nppb), ... system. Ultimately, this signal is experienced as an itch. ... similar, the researchers concluded that a similar process probably ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- A shortage of ... health departments across the United States to contain the ... report. The drug, isoniazid (INH), was first used ... to be the core of any first-line treatment for ... to nine months, according to the U.S. Centers for ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 3Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 4Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report 2
... Pa., Aug. 4 On July 27, 2009 Aetna Inc., one ... drop in profit for Q 2 2009. , , ... claim intensity, such as services rendered in a higher cost setting ... for emergency room, ambulatory, laboratory and preventive services." "We are ...
... Expert warns that consequences of osteoporosis go far beyond weak bones, ... a hip have nearly a 25 percent chance of dying in ... five-year death rate for those who have a spinal fracture is ... Aug. 4 issue of the Canadian Medical Association Journal . ...
... , , , , ... of the school year , , ROSEMONT, Ill., Aug. ... to school in the weeks ahead. Shopping for school supplies and ... classes is brewing for both parents and students, mixed with the questions ...
... , ROSEMONT, Ill., Aug. 4 ... such anesthetic drugs as Diprivan (propofol) by the late Michael Jackson, ... agents. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20050125/CGTU021LOGO ... and Maxillofacial Surgeons (AAOMS) and its 8,500 fellows and members who ...
... , , , , ... awareness and research for musculoskeletal diseases , , ... America,s Orthopaedic Services Act of 2009 (AAOS Act), S. 1548, was introduced ... Burr (R-NC). , , This introduction, the first ...
... , , HARRISBURG, Pa., Aug. ... across the state on the new Integrated Care Initiative, an effort ... and Medicaid issues. , , The new health ... create a single source for consumers to work with both agencies, ...
Cached Medicine News:Health News:Aetna 28 Percent Profit Drop Signals Storm Clouds for Healthcare 2Health News:With a Broken Hip Comes Higher Risk for Dying 2Health News:With a Broken Hip Comes Higher Risk for Dying 3Health News:Back-to-School Parents Earn an A+ in Safety: Backpacks, Cheerleading, Football 2Health News:Back-to-School Parents Earn an A+ in Safety: Backpacks, Cheerleading, Football 3Health News:Back-to-School Parents Earn an A+ in Safety: Backpacks, Cheerleading, Football 4Health News:American Association of Oral and Maxillofacial Surgeons Says Only Trained Dental and Medical Practitioners Should Administer and Monitor Anesthesia 2Health News:Access to America's Orthopaedic Services Act of 2009 Introduced in the Senate 2Health News:Access to America's Orthopaedic Services Act of 2009 Introduced in the Senate 3Health News:Pennsylvania Department of Aging Seeks Consumer Input on New Health Care Option 2
(Date:5/23/2013)... -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ) (Intercept), ... and commercialization of novel bile acid therapeutics to treat ... announced that Mark Pruzanski , MD, ... Deutsche Bank Securities 38th Annual Health Care Conference in ... 2013 at 4:10 p.m. ET. About Intercept ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, ... announced today that it will present new results ... an industry conference sponsored by the PML Consortium ... Idec).  JC polyomavirus (JCV) is the causative agent ... tyrosine kinase inhibitor in an extended release formulation, ...
(Date:5/23/2013)... 23, 2013  PAREXEL International Corporation (NASDAQ: ... at the Jefferies Healthcare Conference in New York.  ... Chief Financial Officer, will be making a presentation on ... Monday, June 3, 2013. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
Breaking Medicine Technology:Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2PAREXEL International To Present At Jefferies Healthcare Conference 2
... March 20, 2012  OriGene Technologies today announced the ... and extensively validated monoclonal antibodies under the UltraMAB™ ... antibodies which are exclusively developed by OriGene for ... products available on the market that have been ...
... YORK, March 20, 2012 Reportlinker.com announces that ... its catalogue: The Outlook ... http://www.reportlinker.com/p0192645/The-Outlook-for-Medical-Devices-in-Central-Asia.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Facility The ... total market of 303 million people and a ...
Cached Medicine Technology:OriGene Technologies Announces the Release Specificity-Verified UltraMAB™ Antibodies 2The Outlook for Medical Devices in Central Asia 2The Outlook for Medical Devices in Central Asia 3The Outlook for Medical Devices in Central Asia 4